XML 72 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Pure Sunfarms Acquisition (Details)
10 Months Ended 12 Months Ended
Nov. 02, 2020
USD ($)
shares
Nov. 02, 2020
CAD ($)
Mar. 31, 2019
USD ($)
shares
Nov. 02, 2020
USD ($)
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CAD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2020
CAD ($)
Nov. 02, 2020
CAD ($)
shares
Nov. 01, 2020
USD ($)
Mar. 31, 2020
Mar. 02, 2020
Mar. 31, 2019
CAD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Business Acquisition [Line Items]                              
Stockholders Equity         $ 205,283,000   $ 126,459,000             $ 84,433,000 $ 66,890,000
Retained Earnings [Member]                              
Business Acquisition [Line Items]                              
Stockholders Equity         35,858,000   24,250,000             $ 21,925,000 $ 29,440,000
Pure Sunfarms                              
Business Acquisition [Line Items]                              
Shares acquired accounted under equity method | shares     25,000,000                        
Fair value of assets of disposal groups     $ 18,700                   $ 25,000    
Gain on disposal of assets     $ 13,600                        
Additional equity transferred percent                       2.50%      
Additional Equity Interest Received Fair value         4,700,000     $ 6,500,000              
Payment to acquire equity method investments         $ 11,700,000 $ 16,000,000                  
Equity method ownership percentage         58.70%     58.70%     57.40%        
Emerald Health | Pure Sunfarms                              
Business Acquisition [Line Items]                              
Business Acquisition, Date of Acquisition Agreement Nov. 02, 2020 Nov. 02, 2020                          
Business Acquisition, Name of Acquired Entity Emerald Health Therapeutics Inc. (“Emerald”) Emerald Health Therapeutics Inc. (“Emerald”)                          
Business Acquisition, Percentage of Voting Interests Acquired 100.00%     100.00%         100.00%            
Business Combination, Consideration Transferred, Total $ 60,000,000                            
Payments to Acquire Businesses 45,000,000                            
Promisonary Notes Payable 15,011,000     $ 15,011,000                      
Goodwill $ 23,095,000                            
Gain on revaluation of previously held investment         $ 23,600,000                    
Emerald Health | Pure Sunfarms | Joint Venture                              
Business Acquisition [Line Items]                              
Business Acquisition, Percentage of Voting Interests Acquired                   58.70%          
Investments             $ 41,300,000     $ 62,700,000          
Emerald Health | Pure Sunfarms | Joint Venture | Hypothetical Liquidation Method Ownership [Member]                              
Business Acquisition [Line Items]                              
Percentage of earnings received from joint venture       58.70%     54.00%                
Emerald Health | Pure Sunfarms | Retained Earnings [Member] | Joint Venture                              
Business Acquisition [Line Items]                              
Stockholders Equity         $ 16,276,000         $ 4,980,000          
Emerald Health | Canada, Dollars | Pure Sunfarms                              
Business Acquisition [Line Items]                              
Business Combination, Consideration Transferred, Total   $ 79,900,000                          
Payments to Acquire Businesses   $ 60,000,000                          
Promisonary Notes Payable                 $ 19,900,000            
Common Stock [Member] | Emerald Health | Pure Sunfarms                              
Business Acquisition [Line Items]                              
Number of Shares acquired | shares 36,958,500     36,958,500         36,958,500